Movement Disorders and Neuromodulation Center

Movement Disorders and Neuromodulation Center

Parkinson's Disease Clinical Trials (Not Enrolling)

Chronic Effects of Deep Brain Stimulation on Cortical Local Field Potentials in Parkinson's Disease and Dystonia (Activa PC+S)
Principal Investigator: Philip Starr, MD, PhD

Cortical Stimulation to Treat Mood and Behavioral Symptoms in Parkinson's Disease Patients
Principal Investigator: Philip Starr, MD, PhD

Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Principal Investigator: Jill Ostrem, MD

Implantable Neurostimulator for the Treatment of Parkinson's Disease (INTREPID) 
Principal Investigator: Jill Ostrem, MD

Mindfulness-based Cognitive Therapy for People With Parkinson's Disease and Caregivers
Principal Investigator: Andreea Seritan, MD

Open-Label Safety Study of Glial Cell Line-Derived Neurotrophic Factor Gene Transfer (AAV2- GDNF) in Parkinson's Disease
Principal Investigator: Paul Larson, MD

The Parkinson's Progression Markers Initiative (PPMI)
Principal Investigator: Caroline Tanner, MD, PhD

A Multicenter, Prospective, Longitudinal, Digital Assessment Study of Disease Progression in Subjects With Early, Untreated Parkinson Disease (WATCH-PD)
Principal Investigator: Caroline Tanner, MD, PhD

A Randomized, Double-Blind, Placebo-Controlled, 52-Week Phase II Study to Evaluate the Efficacy of Intravenous RO7046015/Prasinezumab (PRX002) in Participants With Early Parkinson's Disease With a 6-Year All-Participants-on-Treatment Extension (PASADENA) 
Principal Investigator: Caroline Tanner, MD, PhD

A Randomized, Sham Surgery Controlled, Double-blind, Multi-center, Phase 2 Clinical Trial, Evaluating the Efficacy and Safety of VY-AADC02 in Moderate to Advanced Parkinson's Disease Patients With Motor Fluctuations
Principal Investigator: Chadwick Christine, MD